Cue Care allows patients to consult virtually, obtain a prescription and have the medication delivered. Cue Health plans to expand this service to patients who test positive for COVID-19 and provide an antiviral at-home kit for between $79 and $99, according to an Aug. 29 Cue Health news release.
“Early diagnosis and treatment have shown to lead to better health outcomes, which is why we’re proud to deliver timely testing and treatment all within the Cue Health App,” Cue Health CEO Ayub Khattak said. “Cue Care meets the need today for convenient delivery of COVID-19 treatment, and this capability will support our expanding pipeline of future diagnostics tests.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
